Stay updated on AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Sign up to get notified when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.

Latest updates to the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page
- Check6 days agoChange DetectedDifference0.4%

- Check13 days agoChange DetectedThe page's revision label has been updated from v3.5.4 to v3.5.5, signaling a minor update to the page's underlying version tracking.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This indicates a small site update without changes to study information.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page’s UI release/version indicator has been updated from Revision v3.5.2 to Revision v3.5.3.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check93 days agoChange DetectedAdded a new resources entry for Hepatocellular carcinoma and a link to the Genetic and Rare Diseases Information Center. Site revision updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

Stay in the know with updates to AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AFPᶜ³³²T Reduces AFP in Adv HCC Clinical Trial page.